about
Rate of telomere shortening and cardiovascular damage: a longitudinal study in the 1946 British Birth Cohort.Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.Adipose and height growth through childhood and blood pressure status in a large prospective cohort study.Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes.Obesity in the childhood: a link to adult hypertension.Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it.The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs.Blood pressure and vascular alterations with growth in childhood.Inflammatory disorders and atherosclerosis: new therapeutic approaches.Functional, genetic and biochemical biomarkers of peripheral arterial disease.Association between periodontal disease and its treatment, flow-mediated dilatation and carotid intima-media thickness: a systematic review and meta-analysis.Clustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria.4C.01: LIFETIME OBESITY, CARDIOVASCULAR DISEASE AND COGNITIVE FUNCTION: A LONGITUDINAL STUDY FROM THE 1946 BIRTH COHORT.Association between short leukocyte telomere length, endotoxemia, and severe periodontitis in people with diabetes: a cross-sectional survey.Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients.Understanding the relationship between lung function and cardiovascular phenotypes in the young: opportunity for a better cardiovascular risk prevention in adulthood?Essential Hypertension and Functional Microvascular Ageing.A dose-response elevation in hepatic glucose uptake is paralleled by liver triglyceride synthesis and release.Comparison of two automatic methods for the assessment of brachial artery flow-mediated dilation.Targeting Mitochondria in Age-Related Vascular Changes: A New Arrow to the Bow of Antioxidant Treatment?Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis.Statin guidelines: Friend or foes?Inflammation and not cardiovascular risk factors is associated with short leukocyte telomere length in 13- to 16-year-old adolescents.Ethnic Differences in Carotid Intima-Media Thickness Between UK Children of Black African-Caribbean and White European OriginThe relationship between naevus count, memory function and telomere length in the Twins UK cohortArterial hypertension and the turbulent ageing of the aortic valveLuteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced ObesityAging Modulates the Influence of Arginase on Endothelial Dysfunction in ObesityMitochondrial oxidative stress, endothelial function and metabolic control in patients with type II diabetes and periodontitis: A randomised controlled clinical trialUnderstanding the role of genetics in hypertensionThe impact of body mass index on post resuscitation survival after cardiac arrest: A meta-analysisAlbuminuria and diabetes: a question of eye and skin points of viewArterial hypertension in patients under antineoplastic therapy: a systematic reviewCardiac remodeling and vascular changes: Same music with a new instrumentMicrovascular Endothelial Dysfunction in Human Obesity: Role of TNF-αAngiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activationCardiovascular prevention starts from your mouthInvesting in your arteries by spending more time in educationInflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms
P50
Q34644982-796BF7E3-2A2E-478F-B697-4C34A310C7ADQ36014122-4F417429-9A73-4B8C-8C1C-A71B23A02E66Q36193476-32D3C055-A747-4646-A921-55A76E48D445Q36987143-01523B2C-33E1-4124-99A6-F02AC85EA62CQ37438331-6CAFB23B-6254-4D5C-94C5-BA0B44AC3DB6Q37578974-9CCD6CDA-0F79-40D5-BD40-D7B0E54988AAQ37620070-418F605B-BDEF-4A37-9847-4D0BB9E0FDC6Q37921366-89E86B88-A913-42E5-8237-87672EC89627Q37971962-ABA91A99-21EB-419B-9EA1-C1DD94085D54Q38001467-84A314E6-F77B-49B6-A69B-E4681FA065AAQ38228368-BB83B211-41B8-4FD6-AB3E-FDFC1E8975FAQ40303186-B21E4D40-7CA7-4FE0-8C19-6AF162C1DD0EQ40807859-935C1279-602E-42CB-A735-3920A2652C97Q43491487-F65DB281-7ACC-4DD4-BC12-4540358CE0EAQ46172239-EFF9C59F-5679-40A2-8600-14BBE4138F0EQ49722172-37A7BAA1-CC33-429D-9511-1C8F28F7FE0FQ50127484-98E718DD-0EBF-4013-B946-F214CCA09B4CQ51382012-210113AA-D109-4352-A3DE-55281EA1887FQ51751939-F1678B6B-2D45-40B8-A736-BF28C8993486Q52584741-177F38E8-DCF5-4331-AEDE-ACC1290A9456Q53154106-EBFD4BD9-AD5B-4659-958A-F9E455188870Q53278786-A482CCF3-2AA7-430E-AD5E-D81D3C34C42FQ53741298-7060163B-F043-4102-A795-EC9D11FF27F1Q54306068-B44995E3-F1D7-448D-96E9-5938095BE251Q57416261-BC6D917B-0371-4265-9E68-A6ABC73A414CQ57446731-9915E084-1A2E-4A0A-ADAF-B0D068BA4BF6Q57466999-BF8042DE-977F-4828-BF98-0AF6A4C73F78Q57492135-CF907616-108A-4354-8259-C556F78BA8A6Q57818464-AF471BB7-144D-4DE3-91DE-D9072C46F0C6Q59138518-88C05069-ADD5-4EDC-AD8A-4D82046DE5E1Q88144331-B1BABE7C-854F-47AE-84A8-F25AAF59406DQ88166711-2FFCC74E-CA0F-4074-B4DF-142D04F11A28Q88174636-09B6557C-B329-454D-A2D9-EE571D881800Q90959411-35C0EA53-0912-4E5E-9833-D67D992A5730Q91129650-640C4F09-A866-4FCB-AF59-E7F86D5420C3Q91233820-1E10DBA9-BCB1-450B-ADF6-603D4F3F1A00Q91305579-FF359E45-3E84-4366-82B2-8047869AEA5DQ91635589-8EA84A33-F651-4F86-B1E6-A1AF4628B161Q91681834-4C4F3FD7-61BE-4FB8-9080-E9FC12BF1A86Q92037458-121E79FD-35C6-4E79-BFFF-48C36E109E43
P50
description
researcher, ORCID id # 0000-0002-7591-3686
@en
wetenschapper
@nl
name
Stefano Masi
@ast
Stefano Masi
@en
Stefano Masi
@es
Stefano Masi
@nl
type
label
Stefano Masi
@ast
Stefano Masi
@en
Stefano Masi
@es
Stefano Masi
@nl
prefLabel
Stefano Masi
@ast
Stefano Masi
@en
Stefano Masi
@es
Stefano Masi
@nl
P106
P21
P31
P496
0000-0002-7591-3686